Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole in Bipolar Depression
NCT00376220Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- May 2004
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bipolar disorder (BD) comparing Riluzole with Placebo (2 arms). Primary endpoint: Montgomery-Asberg Depression Rating Scale Total Score at 8 weeks. Started May 2004; status: completed.
02
Drugs
riluzole
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00376220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376220.